Avicanna Inc experienced a notable decline in stock price this week amid a backdrop of recent company developments.
This week, Avicanna Inc (AVCN.TO) saw its stock price drop significantly, closing at C$0.10, down 13.04% on the day and 9.09% over the week. The company has been active in the medical cannabis sector, with several recent announcements that may influence investor sentiment.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$15.45M
52W high
$0.28
52W low
$0.10
1W change
-9.09%
Beta
0.35
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 600.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+600.0% Upside
Current Price
C$0.10
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
102.7%
Annualized
90-Day Vol
84.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.09 | C$0.07 – C$0.13 |
| 60 trading days | C$0.09 | C$0.05 – C$0.15 |
| 90 trading days | C$0.08 | C$0.05 – C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Despite a challenging week for Avicanna, recent announcements regarding financial performance and strategic initiatives could signal potential growth opportunities in the future.
Avicanna's stock down 54.55% YTD amid mixed performance.
The stock's performance has been volatile, with a 52-week range of C$0.10 to C$0.28, reflecting investor uncertainty in the medical cannabis space.
Bull case
Avicanna reported record quarterly revenue and gross profit, showing strong operational performance. The recent decision by the U.S. Department of Justice to reschedule medical cannabis may open new markets for Avicanna's products, providing a promising outlook for growth.
Bear case
The significant decline in stock price and ongoing negative profit margins highlight the financial challenges Avicanna faces. Investors may remain cautious until there are clearer signs of consistent profitability.
Price Action
Advertisement
Avicanna Inc's stock closed at C$0.10, reflecting a significant decrease of 13.04% today and a decline of 9.09% over the past week. Year-to-date, the stock has dropped 54.55%, indicating substantial volatility and investor concern.
Recent Company News
Avicanna recently announced record quarterly revenue and gross profit, driven by growth in Canada and the expansion of its proprietary product portfolio. The company also welcomed the U.S. Department of Justice's decision to reschedule certain cannabinoid-based products, which aligns with its pharmaceutical strategy. Additionally, Avicanna launched MyMedi.ca, an integrated healthcare program aimed at incorporating medical cannabis care into Canadian healthcare institutions.
Technical Picture
The technical indicators for Avicanna show a last close of C$0.10, which is below both the 50-day moving average of C$0.12 and the 200-day moving average of C$0.15, indicating bearish momentum. The stock's 52-week range is C$0.10 to C$0.28, with the current price at the lower end of this range. The beta of 0.35 suggests lower volatility compared to the broader market, while the recent trading volume of 81,500 shares is above the 20-day average volume of 65,747 shares, indicating increased interest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
